STK11 and Alzheimer disease: This rQTL hence not only supports a role of STK11 in AD pathology but it also provides further insights into the putative underlying biological pathways, suggesting that medicinal modification of STK11 or its phosphorylation targets may affect the AD-related phenotypes.